AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,661 | +0.0% | 234 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $4,659 | -11.2% | 234 | 0.0% | 0.00% | -25.0% |
Q4 2023 | $5,249 | +10.9% | 234 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $4,731 | -20.9% | 234 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $5,981 | -14.1% | 234 | 0.0% | 0.01% | -28.6% |
Q1 2023 | $6,959 | +9.9% | 234 | 0.0% | 0.01% | +16.7% |
Q4 2022 | $6,332 | +26.6% | 234 | 0.0% | 0.01% | +20.0% |
Q3 2022 | $5,000 | -16.7% | 234 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $6,000 | -25.0% | 234 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $8,000 | 0.0% | 234 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $8,000 | +14.3% | 234 | 0.0% | 0.01% | +25.0% |
Q3 2021 | $7,000 | -22.2% | 234 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $9,000 | -10.0% | 234 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $10,000 | -9.1% | 234 | 0.0% | 0.01% | -12.5% |
Q4 2020 | $11,000 | +37.5% | 234 | 0.0% | 0.01% | +14.3% |
Q3 2020 | $8,000 | +14.3% | 234 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $7,000 | – | 234 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |